Voyager Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.

CEO

Alfred W. Sandrock

CEOAlfred W. Sandrock

Employees

172

Employees172

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2013

Founded2013

Employees

172

Employees172

VYGR Key Statistics

Market cap

194.33M

Market cap194.33M

Price-Earnings ratio

-3.14

Price-Earnings ratio-3.14

Dividend yield

—

Dividend yield—

Average volume

291.91K

Average volume291.91K

High today

$3.55

High today$3.55

Low today

$3.40

Low today$3.40

Open price

$3.49

Open price$3.49

Volume

199.55K

Volume199.55K

52 Week high

$9.55

52 Week high$9.55

52 Week low

$2.75

52 Week low$2.75

Analyst ratings

100%

of 12 ratings

Buy

100%

Hold

Sell

Voyager Therapeutics

Why Robinhood?

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. Show more

VYGR Key Statistics

Analyst ratings

100%

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.